期刊文献+

玻璃体内注射曲安奈德的问题与并发症 被引量:39

原文传递
导出
摘要 玻璃体内注射曲安奈德(TA)一方面是利用其较强而持久的抗炎和抗新生血管作用,治疗多种与炎症过程相关的眼底疾病,主要包括多种原因所致的黄斑水肿,严重葡萄膜炎,眼内新生血管等;另一方面是利用其白色结晶的附着作用辅助玻璃体切割手术中识别玻璃体,或利用其抗炎作用硅油内注射减轻手术后炎症反应或增生性病变的发生。临床应用中也逐渐发现TA玻璃体内注射存在一些问题。首先是疗效的局限性,表现为作用不能持久,水肿易复发等;其次是药物有关的并发症,包括暂时性高眼压或继发性开角型青光眼,诱发或加重白内障,感染性或非感染性眼内炎等。眼内炎等并发症还可能误诊误治。现对玻璃体内注射TA的局限性和并发症等问题进行综述,以期对国内开展这方面工作提供借鉴。
作者 刘武 王景昭
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2005年第4期267-270,共4页 Chinese Journal of Ocular Fundus Diseases
  • 相关文献

参考文献40

  • 1Jager RD, Aiello LP, Patel SP, et al. Risks of intravitreous injection: a comprehensive review. Retina, 2004,24: 676-698.
  • 2Rycroft B. Penicillin and the control of deep intraocular infection.Br J Ophthalmol, 1945,29:57-87.
  • 3Forster RK, Zachary IG, Cottingham AJ, et al. Further observations on the diagnosis, cause, and treatment of endophthalmitis. Am J Ophthalmol, 1976,81: 52-56.
  • 4Penfold PL, Gyory JF, Hunyor AB, et al. Exudative macular degeneration and intravitreal triamcinolone:a pilot study. Aust N ZJ Ophthalmol, 1995,23:293-298.
  • 5Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol, 2004,122:1131-1136.
  • 6Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema:preliminary results of a prospective controlled trial.Ophthalmology, 2004,111: 218-224.
  • 7Jonas JB, Harder B, Kamppeter BA. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol, 2004,138: 970-977.
  • 8Audren F, Tod M, Massin P, et al. Pharmacokineticpharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci, 2004,45:3435-3441.
  • 9Jonas JB, Degenring RF, Kamppeter BA, et al. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol, 2004, 138:158-160.
  • 10Wingate RJB, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol, 1999,27:431-432.

二级参考文献4

  • 1Jost B. Jonas,Ingrid Kreissig,Robert F. Degenring. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(9):782~783
  • 2Taiji Sakamoto,Miho Miyazaki,Toshio Hisatomi,Takao Nakamura,Akifumi Ueno,Keiko Itaya,Tatsuro Ishibashi. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdown[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(6):423~429
  • 3Yu-sheng Wang,Ulrike Friedrichs,Wolfram Eichler,Stephan Hoffmann,Peter Wiedemann. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(1):42~48
  • 4Yan-Nian Hui,Hou-Cheng Liang,Yong-Shu Cai,Bernd Kirchhof,Klaus Heimann. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretionopathy induced by macrophages[J] 1993,Graefe’s Archive for Clinical and Experimental Ophthalmology(2):109~114

共引文献88

同被引文献307

引证文献39

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部